Global Automatic Cell Imaging System Market Is Anticipated To Witness Significant Growth Due To Rising Research Initiatives And Growing Approval Of High-Content Screening Techniques

Automatic Cell Imaging System

Overview:

An automatic cell imaging system is a laboratory instrument that is used to identify, isolate and analyze cells. This type of device helps in making drugs and therapies for different life-threatening diseases such as cancer. This device is useful in observing and quantifying complex biological changes over hours, days or weeks at the cellular level. This is achieved by capturing high-resolution fluorescence and bright field images that are stored in real-time and recorded over time. The device is suitable for various applications, including apoptosis, cytotoxicity, immune cell killing, neurite analysis, and tumor spheroids. Its integrated software simplifies data analysis to speed time to answer while producing publication-quality graphs and plots. This automated device can be operated in brightfield, colorimetric or fluorescence modes to capture image information with ease. It also provides preconfigured analysis protocols ranging from cell counting to sophisticated neurite tracing to remove the guesswork of optimizing parameters.

Market Dynamics:

Increasing product launches are estimated to augment the growth of the global automatic cell imaging system market over the forecast period. For instance, a new live-cell imaging system was introduced by CytoSMART Technologies in May 2020. The CytoSMART Lux2 Duo Kit offers a cost-effective solution to researchers who are conducting side-by-side comparisons between cell cultures. Moreover, the rising cost of the automatic cell imaging system is anticipated to restrain the growth of the global automatic cell imaging system market over the forecast period.

Impact of COVID-19:

COVID-19 had a significant impact on the global automated cell imaging system market. During the pandemic, the healthcare sector was under immense pressure. The pandemic affected more than 100 nations and the number of COVID-19 cases were increasing on a daily basis. This led to an increase in hospitalizations and rise in testing. This resulted in rising demand for automatic cell imaging systems. These systems offered better testing on live cells and also improved results. This had a positive impact on the growth of the global automatic cell imaging system market during the pandemic. However, in the post-pandemic era, the market is estimated to witness robust growth as several restrictions have been eased across the globe.

Key Takeaways:

The global automatic cell imaging system market is expected to witness high growth, exhibiting a CAGR of 8.7 % over the forecast period, due to increasing acquisitions by key players. For instance, Axion BioSystems, acquired CytoSMART Technologies, a Netherlands-based innovator in kinetic live-cell imaging analysis, in March 2022.

North America is anticipated to witness significant growth in the global automatic cell imaging system market over the forecast period, owing to the growing prevalence of cancer and increasing demand for sustainable treatment plans.

Major players operating in the global automatic cell imaging system market are GE Healthcare, Thermo Fisher Scientific, Biotek Instruments, Spectral Instruments, Logos Biosystems, PerkinElmer, Molecular Devices LLC, Olympus, and Nikon Instruments.